Gene Finley Selected Research

Gene Finley Research Topics

10	Neoplasms (Cancer) 09/2021 - 01/2016
8	Adenocarcinoma 06/2021 - 01/2016
5	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2018
4	Rectal Neoplasms (Rectal Cancer) 09/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2018
2	Brain Neoplasms (Brain Tumor) 01/2022 - 04/2019
1	Celiac Disease (Celiac Sprue) 06/2021
1	Sepsis (Septicemia) 01/2021
1	Colonic Neoplasms (Colon Cancer) 03/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Microsatellite Instability 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Carcinogenesis 11/2018
1	Melanoma (Melanoma, Malignant) 11/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018

3	atezolizumabIBA 01/2022 - 06/2018
3	Bevacizumab (Avastin)FDA Link 01/2022 - 06/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2019
1	Trinitrotoluene (TNT)IBA 09/2021
1	pembrolizumabIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 06/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2018
1	B7-H1 AntigenIBA 06/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2016

11	Drug Therapy (Chemotherapy) 01/2022 - 06/2018
5	Therapeutics 01/2020 - 11/2018
5	Radiotherapy 01/2020 - 10/2018
3	Neoadjuvant Therapy 09/2021 - 10/2019
1	Adjuvant Chemotherapy 09/2021
1	Immunotherapy 06/2021
1	Adjuvant Radiotherapy 03/2020
1	Chemoradiotherapy 10/2019
1	Adjuvant Chemoradiotherapy 01/2019